These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33241607)

  • 1. Generalizing randomized trial findings to a target population using complex survey population data.
    Ackerman B; Lesko CR; Siddique J; Susukida R; Stuart EA
    Stat Med; 2021 Feb; 40(5):1101-1120. PubMed ID: 33241607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing statistical methods for generalizing randomized trial findings to a target population.
    Ackerman B; Schmid I; Rudolph KE; Seamans MJ; Susukida R; Mojtabai R; Stuart EA
    Addict Behav; 2019 Jul; 94():124-132. PubMed ID: 30415786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.
    Li F; Buchanan AL; Cole SR
    J R Stat Soc Ser C Appl Stat; 2022 Jun; 71(3):669-697. PubMed ID: 35968541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study Designs for Extending Causal Inferences From a Randomized Trial to a Target Population.
    Dahabreh IJ; Haneuse SJA; Robins JM; Robertson SE; Buchanan AL; Stuart EA; Hernán MA
    Am J Epidemiol; 2021 Aug; 190(8):1632-1642. PubMed ID: 33324969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.
    Dahabreh IJ; Robertson SE; Tchetgen EJ; Stuart EA; Hernán MA
    Biometrics; 2019 Jun; 75(2):685-694. PubMed ID: 30488513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional cross-design synthesis estimators for generalizability in Medicaid.
    Degtiar I; Layton T; Wallace J; Rose S
    Biometrics; 2023 Dec; 79(4):3859-3872. PubMed ID: 37018228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the performance of statistical methods that generalize effect estimates from randomized controlled trials to much larger target populations.
    Schmid I; Rudolph KE; Nguyen TQ; Hong H; Seamans MJ; Ackerman B; Stuart EA
    Commun Stat Simul Comput; 2022; 51(8):4326-4348. PubMed ID: 36419543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving transportability of randomized controlled trial inference using robust prediction methods.
    Elliott MR; Carroll O; Grieve R; Carpenter J
    Stat Methods Med Res; 2023 Dec; 32(12):2365-2385. PubMed ID: 37936293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing Systematic Missing Data in the Context of Causally Interpretable Meta-analysis.
    Barker DH; Bie R; Steingrimsson JA
    Prev Sci; 2023 Nov; 24(8):1648-1658. PubMed ID: 37726579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.
    Buchanan AL; Hudgens MG; Cole SR; Mollan KR; Sax PE; Daar ES; Adimora AA; Eron JJ; Mugavero MJ
    J R Stat Soc Ser A Stat Soc; 2018 Oct; 181(4):1193-1209. PubMed ID: 30555215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data.
    Stuart EA; Rhodes A
    Eval Rev; 2017 Aug; 41(4):357-388. PubMed ID: 27491758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transportability of Trial Results Using Inverse Odds of Sampling Weights.
    Westreich D; Edwards JK; Lesko CR; Stuart E; Cole SR
    Am J Epidemiol; 2017 Oct; 186(8):1010-1014. PubMed ID: 28535275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Subgroup Effects in Generalizability and Transportability Analyses.
    Robertson SE; Steingrimsson JA; Joyce NR; Stuart EA; Dahabreh IJ
    Am J Epidemiol; 2024 Jan; 193(1):149-158. PubMed ID: 35225329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalizing observational study results: applying propensity score methods to complex surveys.
    Dugoff EH; Schuler M; Stuart EA
    Health Serv Res; 2014 Feb; 49(1):284-303. PubMed ID: 23855598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention.
    Susukida R; Crum RM; Stuart EA; Mojtabai R
    Am J Addict; 2018 Apr; 27(3):231-237. PubMed ID: 29569403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity analysis using bias functions for studies extending inferences from a randomized trial to a target population.
    Dahabreh IJ; Robins JM; Haneuse SJA; Saeed I; Robertson SE; Stuart EA; Hernán MA
    Stat Med; 2023 Jun; 42(13):2029-2043. PubMed ID: 36847107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal inference of latent classes in complex survey data with the estimating equation framework.
    Kang J; He Y; Hong J; Esie P; Bernstein KT
    Stat Med; 2020 Feb; 39(3):207-219. PubMed ID: 31846099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the generalizability of randomized trial results to target populations.
    Stuart EA; Bradshaw CP; Leaf PJ
    Prev Sci; 2015 Apr; 16(3):475-85. PubMed ID: 25307417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Relation Between G-formula and Inverse Probability Weighting Estimators for Generalizing Trial Results.
    Dahabreh IJ; Robertson SE; Hernán MA
    Epidemiology; 2019 Nov; 30(6):807-812. PubMed ID: 31517670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.